Alto Neuroscience (Alto Neuroscience) Other Current Receivables : $0.00 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Other Current Receivables?

Alto Neuroscience's Other Current Receivables for the quarter that ended in Mar. 2024 was $0.00 Mil.

Alto Neuroscience's annual Other Current Receivables declined from Dec. 2021 ($0.25 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.01 Mil).

Alto Neuroscience Other Current Receivables Historical Data

The historical data trend for Alto Neuroscience's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Other Current Receivables Chart

Alto Neuroscience Annual Data

Trend

Dec21

Dec22

Dec23

Other Current Receivables

0.25

0.01

Alto Neuroscience Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Other Current Receivables	Get a 7-Day Free Trial			-	-	-	0.01	-

Alto Neuroscience Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Alto Neuroscience Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience (Alto Neuroscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus

Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc

By GuruFocus Research • 02-08-2024